Congress·In Committee·H.R. 685

Representative Latta Proposes Bill to Ban New Abortion Drugs and Require In-Person Doctor Visits

SAVE Moms and Babies Act of 2025

about 1 year ago·View on Congress.gov

⏸

Stalled

No legislative action in over 90 days.

Legislative Progress

House

Senate

President

Law

Key Points

This bill would stop the FDA from approving any new drugs used for abortions and would end ongoing medical research into new abortion medications after three years.
For drugs already on the market, the bill bans mail-order delivery and pharmacy pickups, requiring patients to get the medicine in person from a doctor at a clinic, medical office, or hospital.
Doctors who prescribe these drugs would need special certification and must be able to perform surgery or provide blood transfusions if a patient has a serious medical emergency.
The policy limits the use of these drugs to the first 70 days of pregnancy and prevents the government from ever extending that time limit or loosening the rules for how they are given to patients.
Manufacturers and healthcare providers would be required to report all serious complications, hospitalizations, and deaths related to the drugs to the FDA to monitor safety.

HealthcareCivil Rights

Impact Analysis

Personal Impact

Who is affectedScoreImpactCertaintyScopeDurationSentiment

Scores: 1 = low, 5 = highSentiment: -5 to +5 (net benefit)

Milestones

2 milestones2 actions

Jan 23, 2025House

Referred to the House Committee on Energy and Commerce.

Jan 23, 2025

Introduced in House

Related News

5 articles

Nasdaq·about 1 year ago

New Bill: Representative Robert E. Latta introduces H.R. 685: Support And Value Expectant Moms and Babies Act of 2025

The bill prohibits the approval of new abortion drugs by the HHS Secretary and prevents investigational use exemptions for drugs in research phases. For existing drugs, it bans pharmacy dispensing and mail-order delivery, requiring in-person administration by a certified healthcare practitioner.

FSMB·about 1 year ago

Additional Licensure Pathways Bill Meets Resistance

The SAVE Moms and Babies Act of 2025 (H.R. 685), introduced by Rep. Bob Latta, would prohibit the approval of new abortion drugs and label changes to existing medications. It requires administration in an office setting and imposes strict reporting requirements on adverse effects.

Mississippi Free Press·about 1 year ago

Hyde-Smith Bill Targets Medication Abortions with 'SAVE Moms and Babies Act'

Senator Cindy Hyde-Smith reintroduced the SAVE Moms and Babies Act to prevent the FDA from lifting regulations on abortion medication. The bill aims to block mail-order distribution and telemedicine prescriptions, while critics argue it ignores data showing serious complications are rare.

CL~